Scripts Rx Pharmacy
Matthew Cunningham has a diverse work experience spanning multiple industries and roles. Matthew is currently the CEO/Founder of Scripts Rx Pharmacy, a nationally-licensed and accredited health care services company and pharmacy specializing in specialty manufacturers and patient access concerns. Prior to this, Matthew served as the Vice President at Avondale, an advisory and principle investing firm focused on business growth. Matthew also worked as a Consultant at Accenture and an Associate at Huron Consulting Group.
Matthew Cunningham attended Miami University from 2003 to 2007, where they earned a Bachelor of Science degree in Finance. Matthew also studied Marketing and pursued a minor in Entrepreneurship during their time at the university.
This person is not in any teams
This person is not in any offices
Scripts Rx Pharmacy
1 followers
Scripts Rx is a fast-growing, hub pharmacy company that helps manufacturers address common patient access concerns while providing a next generation pharmacy experience for doctors and patients. We employ highly skilled pharmacy technicians, pharmacists, and industry professionals, coupling industry expertise with innovative technology, process, and strategic solutions to change the way people think about pharmacy. Scripts Rx Pharmacy was established with a mission to change the way doctors, patients, and drug manufacturers think about pharmacy. Pharmacies today are dependent upon antiquated processes, approaches, and technologies that prevent them from adapting to the ever-evolving needs of patients and doctors. At Scripts Rx, we are focused on building innovative solutions and new approaches that challenge traditional pharmacy norms to achieve the best possible outcomes for the patient while significantly improving the way doctors’ offices interact with pharmacy Scripts Rx provides its services to doctors and patients across the country through its physical locations in Chicago and Houston. Scripts Rx has experienced rapid growth and now and is continuing to build a foundation of innovative technology solutions that has allowed it to double in size each year since its founding in 2016.